|Nevro to Highlight Substantial Body of Clinical Evidence Supporting Expanded Applications and Unique Capabilities of HF10 Therapy at the 14th International Neuromodulation Society World Congress|
|By: PR Newswire Association LLC. - 26 May 2019||Back to overview list
SYDNEY, May 26, 2019 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations supporting the use of the Company's HF10™ therapy for patients with chronic pain. Results will be presented at the International Neuromodulation Society (INS) meeting being held this week in Sydney, Australia.
This year, 26 abstracts on HF10 therapy will be presented at INS, including ten prospective studies; ten retrospective studies; one clinical study design presentation, and five mechanism of action studies. Eight of the prospective studies and four of the retrospective studies will also be presented on the podium. The broad range of research investigates both new and established pain areas, programming techniques with HF10 therapy, and preclinical studies to understand the unique mechanism of action with HF10 therapy.
"Nevro is committed to expanding the field of neuromodulation with our growing body of clinical evidence that supports the use of HF10 therapy," said D. Keith Grossman, Chairman, CEO and President of Nevro. "The results of these studies demonstrate that our best-in-class therapy can significantly improve the lives of patients suffering from various forms of debilitating chronic pain."
Details of the presentations and schedule (dates/times AEST) include:
Monday, May 27, 2019
17:00-17:10 Spinal Cord Stimulation at 10 kHz for the Treatment of Chronic Focal Neuropathic Post-Surgical Pain
17:10-17:20 Spinal Cord Stimulation at 10 kHz for the Treatment of Chronic Pain of the Upper Extremities: Results of a Prospective, Multicenter, Post-Market, Observational Study
17:30-17:40 High frequency spinal cord stimulation (HF-SCS) at 10 kHz for the treatment of chronic pain resulting from spinal cord injury
Tuesday, May 28, 2019
17:10-17:20 Treatment of chronic abdominal pain with 10 KHz Spinal Cord Stimulation: Efficacy results from a 12 month prospective, multicenter, feasibility study in a series of patients with diverse pain etiologies
17:40-17:50 Pulse Dosing of 10 kHz Paresthesia-Independent Spinal Cord Stimulation Provides Same Efficacy with Substantial Reduction of Device Recharge Time
18:10-18:20 Prospective, Open Label, Pilot Study: One Year Results Of 10kHz Spinal Cord Stimulation (SCS) For Neuropathic Back Pain in Non-Operated Patients: The Maiden-Back Study
Wednesday, May 29, 2019
17:10-17:20 Spinal Cord Stimulation at 10 kHz For Chronic Intractable Leg Pain: Australian Experience
17:20-17:30 Spinal Cord Stimulation at 10 kHz for Treatment of Chronic Head Pain
17:50-18:00 Electropsychophysical Characterization of High-kHz Epidural Spinal Cord Stimulation
High Frequency Spinal Cord Stimulation at 10 kHz for the Treatment of Focal, Chronic, Post-Surgical Neuropathic Pain
High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz for the Treatment of Neuropathic Limb Pain from Painful Diabetic Neuropathy
A Multicenter Real-World Review of 10 kHz Spinal Cord Stimulation Outcomes for the Treatment of Chronic Trunk and/or Limb Pain in USA
Spinal Cord Stimulation at 10 kHz for Treatment of Elhers Danlos Syndrome
Cluneal Nerve Stimulation at 10 kHz for the Treatment of Chronic Neuropathic Pain
Improved Chronic Widespread Pain and Motor Function using High Frequency Spinal Cord Stimulation (HF-SCS) at 10 kHz: A Case Study
Spinal Cord Stimulation at 10 kHz for Chronic Intractable Pain: A Prospective Case Series in a Real-World Community Practice
Spinal Cord Stimulation at 10 kHz for Treatment of Chronic Pain in a Compensable Setting
Pre-clinical and MoA Posters
Comparing the Firing Patterns of Superficial Dorsal Horn Neurons Evoked by Robotically Automated and Human Manual Brushing and Von Frey Hair Stimulation
Electrical Activity Evoked by 10 kHz Spinal Cord Stimulation on Superficial Dorsal Horn Neurons in Neuropathic Pain Rats
Differential modulation of spinal dorsal horn neurons by various spinal cord stimulation strategies
High Frequency kHz Spinal Cord Stimulation (SCS) Modulate Spinal Dorsal Horn Neurons in Neuropathic Pain Rats
About Nevro Corp.
View original content to download multimedia:http://www.prnewswire.com/news-releases/nevro-to-highlight-substantial-body-of-clinical-evidence-supporting-expanded-applications-and-unique-capabilities-of-hf10-therapy-at-the-14th-international-neuromodulation-society-world-congress-300856892.html
SOURCE Nevro Corp.
Copyright 2019 PR Newswire Association LLC.
|Back to overview list|